Tag: bioprinting
-
NASA Spaceline Current Awareness List #1,169 (October 10, 2025): Space Life Science Research Results and Funding Highlights
Overview of NASA-backed Space Life Science Findings The latest NASA Spaceline Current Awareness List (#1,169) dated 10 October 2025 offers a comprehensive snapshot of recent research results in space life science, with a focus on studies supported by NASA funding. The compilation highlights diverse topics—from the effects of spaceflight on task performance to regenerative medicine…
-
MEDS: Ingestible Bioprinter for Non-Invasive Tissue Repair
What is MEDS and why it matters Researchers at EPFL’s Laboratory for Advanced Fabrication Technologies have unveiled MEDS, the Magnetic Endoluminal Deposition System. This pioneering device marks a new step in bioprinting by marrying the precision of tissue fabrication with the safety and practicality of an ingestible capsule. Unlike traditional, bulky bioprinters that require anesthesia…
-
Ingestible Bioprinter MEDS: A Breakthrough for Minimally Invasive GI Tissue Repair
A New Frontier in GI Tissue Repair Researchers at EPFL’s Laboratory for Advanced Fabrication Technologies have unveiled MEDS (Magnetic Endoluminal Deposition System), the first ingestible bioprinter designed to repair tissue from inside the body. Unlike bulky surgical tools or tethered devices, MEDS aims to deliver precision bioprinting directly at the site of tissue damage, offering…
-
Ingestible Bioprinter MEDS: A Swallowable Breakthrough for Minimally Invasive Tissue Repair
Overview: A New Class of Minimally Invasive Bioprinting Researchers at the Laboratory for Advanced Fabrication Technologies within EPFL’s School of Engineering have unveiled MEDS (Magnetic Endoluminal Deposition System), a first-of-its-kind ingestible bioprinter. This device aims to repair soft tissue injuries inside the gastrointestinal tract without traditional surgery. By combining a swallowable capsule with a magnet-guided…